CONFERENCE COVERAGE SERIES
Clinical Trials on Alzheimer's Disease 2011
San Diego, CA, U.S.A.
03 – 05 November 2011
Nutrient Formulation Appears to Grease Memory Function
A medical food thought to promote synapse formation was found to improve memory test scores in patients with mild Alzheimer’s disease in a clinical trial...
Door Slams on RAGE
Another drug bites the dust...
Whence and Where To: History and Future of AD Therapy Trials
In Paul Aisen's opening lecture, he narrated the history of the field’s attempts to develop treatments for Alzheimer’s...
Clinical Trials: Making “Protocols From Hell” Less Burdensome
Alzheimer’s disease (AD) trials are extremely burdensome, sometimes unnecessarily so, and hard to comply with to the bitter end for most elderly people...
EEG: Coming in From the Margins of Alzheimer’s Research?
Regular visitors to Alzforum will be familiar with the use of PET, MRI, and cerebrospinal fluid measurements as markers for AD, But these are not the only AD biomarkers...
EEG: Old Method to Lend New Help in AD Drug Development?
CTAD attendees got an earful about an arguably neglected topic in Alzheimer’s research, that is, the use of event-related potentials (ERP) as biomarkers of disease...
Reeling In Biomarker Data in Young Carriers, API Rocks Staging Boat
Scientists driving the Alzheimer's Prevention Initiative have been reporting at scientific conferences the first emerging biomarker findings from their human volunteers...
Time Is Ripe for Clinical Trials in Frontotemporal Degeneration
Researchers in frontotemporal degeneration (FTD) are learning from AD woes and gearing up to take a seat in the front row...
Pieces Move Into Place to Stage Frontotemporal Trials
Speakers wanted to bring frontotemporal degeneration (FTD) to the attention of the pharmaceutical industry and trialists working in Alzheimer’s disease...